News
📈 Stocks
BioNTech Shares Slip as BMO Downgrades Stock Following Clinical Setback
(49 days ago)
BMO Capital Markets downgraded BioNTech to market perform, citing a failed Phase 2 clinical trial and lowered revenue guidance, though the company…